Get started
Author

Yoshiyuki Yamaguchi

Observed names: Y Yamaguchi, Y. Yamaguchi, YAMAGUCHI, Yoshiyuki, YOSHIYUKI YAMAGUCHI, Yamaguchi, Y., Yamaguchi, Yoshiyuki, Yoshiyuki YAMAGUCHI
Observed institutions: Hiroshima University, Kyushu University, Kawasaki Medical School, Kawasaki Medical School Hospital, Saiseikai Hiroshima Hospital, Research Institute for Radiation Biology and Medicine, Hiroshima University
ORCID: 0000-0001-5895-9044
Observed ORCID: 0000-0001-5895-9044
OpenAlex ID: A5025758494
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer
2004 · Shunji Matsumura, Naohide Oue, et al. · Journal of Cancer Research and Clinical Oncology · 125
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
2008 · Masahiro Ohara, Yoshiyuki Yamaguchi, et al. · Cancer Immunology Immunotherapy · 98
PDF
Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice
2004 · Kazuyoshi Yanagihara, Hiromi Tanaka, et al. · Cancer Science · 94
PDF
CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer
2005 · Riki Okita, Toshiaki Saeki, et al. · Oncology Reports · 89
Maturation of dendritic cells and T‐cell responses in sentinel lymph nodes from patients with breast carcinoma
2006 · Kazuo Matsuura, Yoshiyuki Yamaguchi, et al. · Cancer · 82
PDF
A Single Nucleotide Polymorphism in the 5′ Untranslated Region of the EGF Gene Is Associated with Occurrence and Malignant Progression of Gastric Cancer
2005 · Yoichi Hamai, Shunji Matsumura, et al. · Pathobiology · 56
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502
2015 · S. Sadahiro, T. Tsuchiya, et al. · Annals of Oncology · 55
PDF
Efficacy and Safety of Orally Administered Lentinula edodes Mycelia Extract for Patients Undergoing Cancer Chemotherapy: A Pilot Study
2011 · Yoshiyuki Yamaguchi, Eiji Miyahara, et al. · The American Journal of Chinese Medicine · 55
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
2018 · Shoichi Hazama, Koji Tamada, et al. · Annals of Gastroenterological Surgery · 52
PDF
Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles
2018 · Yoshiko Mori, Akihiro Nyuya, et al. · Oncotarget · 42
PDF
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
2015 · Riki Okita, Diana Wolf, et al. · PLoS ONE · 42
PDF
A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer
2004 · Shunji Matsumura, Naohide Oue, et al. · Journal of Cancer Research and Clinical Oncology · 39
Adoptive Immunotherapy of Cancer using Activated Autologous Lymphocytes -Current Status and New Strategies-
2003 · Yoshiyuki YAMAGUCHI, Akiko OHSHITA, et al. · Human Cell · 33
Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.
2000 · T Toge, Y Yamaguchi · Oncology Reports · 30
Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency
2018 · Naosuke Yokomichi, Naoshi Nishida, et al. · Liver Cancer · 26
Regulating surgical oncotaxis to improve the outcomes in cancer patients
2013 · Toshihiro Hirai, Hideo Matsumoto, et al. · Surgery Today · 26
Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer.
2007 · Jun Hihara, Kazuhiro Yoshida, et al. · PubMed · 26
Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2: Induction of autologous tumour-reactive CD4+ Th1 killer lymphocytes
2003 · Y Yamaguchi, E Miyahara, et al. · British Journal of Cancer · 26
PDF
Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
2009 · Ichiro Nagamine, Yoshiyuki Yamaguchi, et al. · PubMed · 23
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device
2017 · Akira Yamauchi, Masahiro Yamamura, et al. · BMC Cancer · 22
PDF
Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
2006 · Katsuji Hironaka, Yoshiyuki Yamaguchi, et al. · PubMed · 22
Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: Possible application for compensatory anti-inflammatory response syndrome
2006 · Yoshiyuki Yamaguchi, Jun Hihara, et al. · Oncology Reports · 21
PDF
Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
1995 · Y Yamaguchi, Y Satoh, et al. · PubMed · 21
Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations
2021 · Takashi Kawai, Akihiro Nyuya, et al. · Clinical Epigenetics · 20
PDF
Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.
2005 · Yoshiyuki Yamaguchi, Koji Ohta, et al. · PubMed · 18
Works count: 142
Citation count: 1,489
H-index: 21
I10-index: 38
Year
Topic
Type